| Triggering factors | | | | |
| Infection (n [%]) | 39 (37.9) | 29 (34.1) | 10 (55.6) | 0.088 |
| Acute neurological disease (n [%]) | 3 (2.9) | 2 (2.4) | 1 (5.6) | 0.442 |
| Post-surgery (n [%]) | 4 (3.9) | 3 (3.5) | 1 (5.6) | 0.542 |
| Psychological stress (n [%]) | 2 (1.9) | 2 (2.4) | 0 (0.0) | 1.000 |
| Unknown (n [%]) | 45 (43.7) | 41 (48.2) | 4 (22.2) | 0.066 |
| Treatment | | | | |
| Invasive mechanical ventilation (n [%]) | 39 (37.9) | 24 (28.2) | 15 (83.3) | <0.001 |
| Renal replacement therapy (n [%]) | 8 (7.8) | 3 (3.5) | 5 (27.8) | 0.004 |
| Dobutamin (n [%]) | 24 (23.3) | 15 (17.6) | 9 (50.0) | 0.003 |
| Adrenalin (n [%]) | 18 (17.6) | 8 (9.4) | 10 (55.6) | <0.001 |
| Noradrenalin (n [%]) | 42 (40.8) | 28 (32.9) | 14 (77.8) | <0.001 |
| Nitro glyceryl (n [%]) | 7 (6.8) | 6 (7.1) | 1 (5.6) | 1.000 |
| Diuretic (n [%]) | 32 (31.1) | 28 (32.9) | 4 (22.2) | 0.576 |
| Antiplatelet (n [%]) | 32 (31.1) | 27 (31.8) | 5 (27.8) | 0.740 |
| Statin (n [%]) | 45 (43.7) | 37 (43.5) | 8 (44.4) | 0.943 |
| ACEi (n [%]) | 18 (17.5) | 16 (18.8) | 2 (11.1) | 0.434 |
| ARB (n [%]) | 22 (21.4) | 21 (24.7) | 1 (5.6) | 0.072 |
| ARNI (n [%]) | 3 (2.9) | 3 (3.5) | 0 (0.0) | 1.000 |
| Beta channel blocker (n [%]) | 18 (17.5) | 17 (20.0) | 1 (5.6) | 0.186 |
| Duration of treatment, day | 10 (4.0–20.0) | 13.5 (3.0–21.0) | 11.5 (5.5–19.0) | 0.790 |